Diabetes Research and Clinical Practice
Volume 72, Issue 1 , Pages 12-19 , April 2006

Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients

  • Kunio Yufu

      Affiliations

    • Department of Internal Medicine 1, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Oita 879-5593, Japan
    • ,
  • Naohiko Takahashi

      Affiliations

    • Department of Internal Medicine 1, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Oita 879-5593, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 97 586 5793; fax: +81 97 549 4480.
    • ,
  • Mikiko Nakagawa

      Affiliations

    • Department of Laboratory Medicine, Faculty of Medicine, Oita University, Oita, Japan
    • ,
  • Masahide Hara

      Affiliations

    • Department of Internal Medicine 1, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Oita 879-5593, Japan
    • ,
  • Tetsunori Saikawa

      Affiliations

    • Department of Laboratory Medicine, Faculty of Medicine, Oita University, Oita, Japan
    • ,
  • Hironobu Yoshimatsu

      Affiliations

    • Department of Internal Medicine 1, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Oita 879-5593, Japan

Received 4 March 2004 ,Revised 6 September 2004 ,Accepted 16 August 2005.

References 

  1. Levin TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am. J. Cardiol. 1981;49:1659–1666
  2. Tsuji H, Venditti FJ, Manders ES, Evans JC, Larson MG, Feldman CL, et al. Reduced heart rate variability and mortality risk in an elderly cohort. Circulation. 1994;90:878–883
  3. Tsuji H, Larson MG, Venditti FJ, Manders ES, Evans JC, Feldman CL, et al. Impact of reduced heart rate variability on risk for cardiac events. Circulation. 1996;94:2850–2855
  4. Bigger TEJ, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 1992;85:164–171
  5. La Rovere MT, Specchia G, Mortara A, Schwartz PJ. Baroreflex sensitivity, clinical correlates and cardiovascular mortality among patients with a first myocardial infarction: a prospective study. Circulation. 1988;78:816–824
  6. La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478–484
  7. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diab. Med. 1993;10:664–671
  8. Reichard P, Phil M. Mortality and treatment side effects during long term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes. 1994;43:313–317
  9. Wilkins MR, Redondo J, Brown LA. The natriuretic-peptide family. Lancet. 1997;349:1307–1310
  10. Nakao K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic peptide system. I. Natriuretic peptides. J. Hypertens. 1992;10:907–912
  11. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195–203
  12. Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CG, et al. Natriuretic peptide system in human heart failure. Circulation. 1993;88:1004–1009
  13. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maede Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997;96:509–516
  14. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 1997;350:1349–1353
  15. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998;351:9–13
  16. Thomas CJ, Head GA, Woods RL. Similar baroreflex bradycardic actions of atrial natriuretic peptide and B and C types of natriuretic peptides in conscious rats. J. Hypertens. 1999;17:801–806
  17. Spallone V, Menzinger G. Diagnosis of cardiovascular autonomic neuropathy in diabetes. Diabetes. 1997;46:S67–S76
  18. Martina ISR, van Koningsveld R, Schmitz PIM, van der Meche FGA, van Doorn PA. Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. J. Neurol. Neurosurg. Psychiatry. 1998;65:743–747
  19. Hotta N, Sugiyama K, Tsuchida I, Sano T, Koh N, Matsumae H, et al. Use of the C64 quantitative Tuning fork and the effect of niceritrol in diabetic neuropathy. Clin. Ther. 1994;16:1007–1015
  20. Yano Y, Katsuki A, Gabazza EC, Ito K, Fujii M, Furuta M, et al. Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. J. Clin. Endocrinol. Metab. 1999;84:2353–2356
  21. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, von Scheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J. Am. Coll. Cardiol. 2001;38:1934–1941
  22. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 1986;67:450–458
  23. Takahashi N, Nakagawa M, Saikawa T, Ooie T, Akimitsu T, Kaneda K, et al. Noninvasive assessment of the cardiac baroreflex: response to downward tilting and comparison with the phenylephrine method. J. Am. Coll. Cardiol. 1999;34:211–215
  24. Takahashi N, Nakagawa M, Saikawa T, Ooie T, Yufu K, Shigematsu S, et al. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients. J. Am. Coll. Cardiol. 2001;38:232–237
  25. Nakagawa M, Takahashi N, Yufu K, Fujino T, Ooie T, Yonemochi H, et al. Malignant neurocardiogenic vasovagal syncope associated with chronic exaggerated vagal tone. PACE. 2000;23:1695–1697
  26. Eckberg DL, Drabinsky M, Braunward E. Defective cardiac parasympathetic control in patients with heart disease. N. Engl. J. Med. 1971;285:877–883
  27. Amorim DS, Dargie HD, Heer K, Brown M, Jenner D, Olsen EGJ, et al. Is there autonomic impairment in congestive (dilated) cardiomyopathy?. Lancet. 1981;1:525–527
  28. Higgins CB, Vatner SF, Eckberg DL, Braunward E. Alterations in the baroreceptor reflex in conscious dogs with heart failure. J. Clin. Invest. 1972;51:715–724
  29. Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjørnerheim R, Endresen K, et al. Natriuretic peptides in patients with aortic stenosis. Am. Heart J. 2001;142:725–732
  30. Frattola A, Parati G, Gamba P, Paleari F, Mauri G, Rienzo MD, et al. Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia. 1997;40:1470–1475
  31. Sakata K, Shirotani M, Yoshida H, Kurata C. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertention. J. Am. Coll. Cardiol. 1998;32:438–443
  32. Ylitalo A, Airaksinen KE, Sellin L, Huikuri HV. Effects of combination antihypertensive therapy on baroreflex sensitivity and heart rate variability in systemic hypertension. Am. J. Cardiol. 1999;83:885–889
  33. Ducher M, Cerutti C, Gustin MP, Abou-Amara S, Thivolet C, Laville M, et al. Noninvasive exploration of cardiac autonomic neuropathy. Diab. Care. 1999;22:388–393
  34. Kondo K, Matsubara T, Nakamura J, Hotta N. Characteristic patterns of circadian variation in plasma catecholamine levels, blood pressure and heart rate variability in type 2 diabetic patients. Diab. Med. 2002;19:359–365
  35. Kyuma M, Nakata T, Hashimoto A, Nagao K, Sasao H, Takahashi T, et al. Incremental prognostic implications of brain natriuretic peptide cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure. J. Nucl. Med. 2004;45:155–163

PII: S0168-8227(05)00361-X

doi: 10.1016/j.diabres.2005.08.011

Diabetes Research and Clinical Practice
Volume 72, Issue 1 , Pages 12-19 , April 2006

Article Tools

* Image Usage & Resolution